|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.92 EUR | +0.97% |
|
+3.10% | +19.87% |
| 11:16am | Modest gains in Europe, oil rebounds | |
| 09:23am | Oil starts the week lower as a busy stretch looms |
Insider Transaction History
Latest insider transactions for Rémy Cointreau
Importance
Delete
Transaction type
Delete
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 02-17 | Andromède SAS
| Fiscal year | Company | 73,000 | 64.79 | 4.73M | 0.1388% | |
| 11-07 | Andromède SAS
| Free | Company | 249,842 | 44.33 | 11.08M | 0.4751% | |
| 11-07 | Orpar SA
| Free | Company | 88,203 | 44.33 | 3.91M | 0.1677% | |
| 21/01/25 | Fiscal year | Chief Executive Officer | 7,858 | 51.35 | 404K | 0.0151% | ||
| 04/10/24 | Free | 226,143 | 67.16 | 15.19M | 0.4412% | |||
| 04/10/24 | Free | 640,564 | 67.16 | 43.02M | 1.2498% | |||
| 19/07/24 | Andromède SAS
| Buy | Company | 163 | 75.00 | 12.22K | 0.0003% | |
| 17/07/24 | Andromède SAS
| Buy | Company | 6,683 | 74.89 | 500K | 0.0130% | |
| 16/07/24 | Andromède SAS
| Buy | Company | 5,294 | 74.94 | 397K | 0.0103% | |
| 15/07/24 | Andromède SAS
| Buy | Company | 1,421 | 74.96 | 107K | 0.0028% | |
| 12/07/24 | Orpar SA
| Buy | Company | 9,000 | 74.50 | 671K | 0.0176% | |
| 11/07/24 | Andromède SAS
| Buy | Company | 10,000 | 73.37 | 734K | 0.0195% | |
| 10/07/24 | Andromède SAS
| Buy | Company | 20,000 | 73.26 | 1.47M | 0.0390% | |
| 09/07/24 | Sell | 73,000 | 74.04 | 5.41M | 0.1424% | |||
| 09/07/24 | Andromède SAS
| Sell | Company | 73,000 | 67.10 | 4.9M | 0.1424% | |
| 09/07/24 | Andromède SAS
| Sell | Company | 73,000 | 64.79 | 4.73M | 0.1424% | |
| 09/07/24 | Andromède SAS
| Sell | Company | 15,000 | 74.31 | 1.11M | 0.0293% | |
| 30/05/24 | Buy | 64,484 | 85.30 | 5.5M | 0.1258% | |||
| 29/05/24 | Buy | 32,014 | 87.70 | 2.81M | 0.0625% | |||
| 28/05/24 | Buy | 347 | 88.00 | 30.54K | 0.0007% | |||
| 28/05/24 | Buy | 10,480 | 87.68 | 919K | 0.0204% | |||
| 24/05/24 | Buy | 5,937 | 87.92 | 522K | 0.0116% | |||
| 09/04/24 | Buy | 2,510 | 87.96 | 221K | 0.0049% | |||
| 19/03/24 | Andromède SAS
| Buy | Company | 37,691 | 91.86 | 3.46M | 0.0735% | |
| 19/03/24 | Andromède SAS
| Buy | Company | 37,691 | 91.86 | 3.46M | 0.0735% | |
| 18/03/24 | Buy | 60,872 | 92.62 | 5.64M | 0.1188% | |||
| 18/03/24 | Buy | 6,545 | 92.96 | 608K | 0.0128% | |||
| 17/03/24 | Buy | 6,545 | 92.96 | 608K | 0.0128% | |||
| 15/03/24 | Buy | 6,545 | 92.96 | 608K | 0.0128% | |||
| 15/03/24 | Buy | 6,545 | 92.96 | 608K | 0.0128% | |||
| 12/03/24 | Buy | 30,900 | 93.64 | 2.89M | 0.0603% | |||
| 12/03/24 | Buy | 23,000 | 94.04 | 2.16M | 0.0449% | |||
| 12/03/24 | Buy | 30,000 | 94.54 | 2.84M | 0.0585% | |||
| 07/03/24 | Buy | Director | 25,000 | 95.96 | 2.4M | 0.0488% | ||
| 05/03/24 | Buy | 4,618 | 97.28 | 449K | 0.0090% | |||
| 04/03/24 | Buy | 6,527 | 97.85 | 639K | 0.0127% | |||
| 01/03/24 | Buy | Director | 8,217 | 98.00 | 805K | 0.0160% | ||
| 28/02/24 | Andromède SAS
| Buy | Company | 8,373 | 97.02 | 812K | 0.0163% | |
| 27/02/24 | Andromède SAS
| Buy | Company | 23,000 | 97.60 | 2.24M | 0.0449% | |
| 21/02/24 | Buy | 20,986 | 99.20 | 2.08M | 0.0409% | |||
| 21/02/24 | Buy | 1,473 | 97.90 | 144K | 0.0029% | |||
| 19/02/24 | Buy | 6,040 | 97.73 | 590K | 0.0118% | |||
| 19/02/24 | Buy | 20,000 | 98.53 | 1.97M | 0.0390% | |||
| 16/02/24 | Buy | 25,000 | 99.81 | 2.5M | 0.0488% | |||
| 16/02/24 | Buy | 9,086 | 97.81 | 889K | 0.0177% | |||
| 15/02/24 | Andromède SAS
| Buy | Company | 25,000 | 97.57 | 2.44M | 0.0488% | |
| 14/02/24 | Buy | 24,000 | 98.43 | 2.36M | 0.0468% | |||
| 13/02/24 | Buy | 15,976 | 99.19 | 1.58M | 0.0312% | |||
| 12/02/24 | Buy | 5,024 | 98.00 | 492K | 0.0098% | |||
| 20/12/23 | Free | Chief Executive Officer | 8,099 | - | - | 0.0158% | ||
- Stock Market
- Stocks
- RCO Stock
- Company Rémy Cointreau
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















